Rituximab-induced hepatitis C virus reactivation in rheumatoid arthritis

Ko Ming Lin; Jing Chi Lin; Wen Yi Tseng; Tien Tsai Cheng

doi:10.1016/j.jmii.2011.12.020

Rituximab-induced hepatitis C virus reactivation in rheumatoid arthritis

Ko Ming Lin, Jing Chi Lin, Wen Yi Tseng, Tien Tsai Cheng^*

^*Corresponding author for this work

Research output: Contribution to journal › Journal Article › peer-review

25 Scopus citations

Abstract

The B-cell depletion agent rituximab (RTX) is used in lymphoma and rheumatoid arthritis (RA), and there have been several case reports of an RTX-induced reactivation of hepatitis C virus in patients with lymphoma. However, there have been no papers detailing hepatitis C virus reactivation after RTX therapy in a patient with RA. Here we report a case of RTX-induced hepatitis C virus reactivation in a patient with RA. Physicians should be aware that a close follow-up of liver function and viral load is mandatory after RTX therapy in patients with RA and concomitant hepatitis C.

Original language	English
Pages (from-to)	65-67
Number of pages	3
Journal	Journal of Microbiology, Immunology and Infection
Volume	46
Issue number	1
DOIs	https://doi.org/10.1016/j.jmii.2011.12.020
State	Published - 02 2013
Externally published	Yes

Keywords

Hepatitis C virus
Rheumatoid arthritis
Rituximab

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jmii.2011.12.020

Cite this

@article{a0e61bff497b478386aea34a810f0a0d,

title = "Rituximab-induced hepatitis C virus reactivation in rheumatoid arthritis",

abstract = "The B-cell depletion agent rituximab (RTX) is used in lymphoma and rheumatoid arthritis (RA), and there have been several case reports of an RTX-induced reactivation of hepatitis C virus in patients with lymphoma. However, there have been no papers detailing hepatitis C virus reactivation after RTX therapy in a patient with RA. Here we report a case of RTX-induced hepatitis C virus reactivation in a patient with RA. Physicians should be aware that a close follow-up of liver function and viral load is mandatory after RTX therapy in patients with RA and concomitant hepatitis C.",

keywords = "Hepatitis C virus, Rheumatoid arthritis, Rituximab",

author = "Lin, {Ko Ming} and Lin, {Jing Chi} and Tseng, {Wen Yi} and Cheng, {Tien Tsai}",

year = "2013",

month = feb,

doi = "10.1016/j.jmii.2011.12.020",

language = "英语",

volume = "46",

pages = "65--67",

journal = "Journal of Microbiology, Immunology and Infection",

issn = "1684-1182",

publisher = "Elsevier Ltd",

number = "1",

}

TY - JOUR

T1 - Rituximab-induced hepatitis C virus reactivation in rheumatoid arthritis

AU - Lin, Ko Ming

AU - Lin, Jing Chi

AU - Tseng, Wen Yi

AU - Cheng, Tien Tsai

PY - 2013/2

Y1 - 2013/2

N2 - The B-cell depletion agent rituximab (RTX) is used in lymphoma and rheumatoid arthritis (RA), and there have been several case reports of an RTX-induced reactivation of hepatitis C virus in patients with lymphoma. However, there have been no papers detailing hepatitis C virus reactivation after RTX therapy in a patient with RA. Here we report a case of RTX-induced hepatitis C virus reactivation in a patient with RA. Physicians should be aware that a close follow-up of liver function and viral load is mandatory after RTX therapy in patients with RA and concomitant hepatitis C.

AB - The B-cell depletion agent rituximab (RTX) is used in lymphoma and rheumatoid arthritis (RA), and there have been several case reports of an RTX-induced reactivation of hepatitis C virus in patients with lymphoma. However, there have been no papers detailing hepatitis C virus reactivation after RTX therapy in a patient with RA. Here we report a case of RTX-induced hepatitis C virus reactivation in a patient with RA. Physicians should be aware that a close follow-up of liver function and viral load is mandatory after RTX therapy in patients with RA and concomitant hepatitis C.

KW - Hepatitis C virus

KW - Rheumatoid arthritis

KW - Rituximab

UR - http://www.scopus.com/inward/record.url?scp=84872606787&partnerID=8YFLogxK

U2 - 10.1016/j.jmii.2011.12.020

DO - 10.1016/j.jmii.2011.12.020

M3 - 文章

C2 - 22627098

AN - SCOPUS:84872606787

SN - 1684-1182

VL - 46

SP - 65

EP - 67

JO - Journal of Microbiology, Immunology and Infection

JF - Journal of Microbiology, Immunology and Infection

IS - 1

ER -

Rituximab-induced hepatitis C virus reactivation in rheumatoid arthritis

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this